PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
4 hedge funds and large institutions have $2.33K invested in PAVmed Inc. Series Z Warrant in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
33% less funds holding
Funds holding: 6 → 4 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
94% less capital invested
Capital invested by funds: $38.8K → $2.33K (-$36.4K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$27.9K |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$7.32K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$39 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2.13K | +$2.57K | +21,272 | New |
|
2
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $120 | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $72 | -$39 | -325 | -35% |
|
4
Bank of America
Charlotte,
North Carolina
| $12 | – | – | – |
|
|
RJA
5
Raymond James & Associates
St Petersburg,
Florida
| – | -$27.9K | -174,542 | Closed |
|
|
LCS
6
Levin Capital Strategies
New York
| – | -$7.32K | -45,775 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$3.2K | -19,982 | Closed |
|
PAVMZ Hedge Fund Activity: Q3 2023 in Review
4 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2023, worth a combined $2.33K — down 94% from $38.8K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PAVMZ and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.57K. The largest seller was Raymond James & Associates, exiting entirely with an estimated $27.9K sold.
- 4 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2023, down from 6 in Q2 2023.
- Funds reported $2.33K of PAVmed Inc. Series Z Warrant stock for Q3 2023, down 94% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q3 2023 and 3 closed out, a net change of -2 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q3 2023 was Susquehanna International Group, an estimated $2.57K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q3 2023 was Raymond James & Associates, an estimated $27.9K sold.
Based on aggregated 13F filings for Q3 2023.